"Family Allergy & Asthma Research Institute has been conducting clinical research since 1991. We are continually recognized for our excellence within the research field. Our site has state-of-the-art technology, a computerized database of more than 15,000 patients and we collaborate with most of the national pharmaceutical and clinical research organizations. We have participated in the clinical trials of allergy medications such as Zyrtec, Allegra, Claritin, Flonase, Nasonex, and many others."

During the past decade, Family Allergy and Asthma Research Institute conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 7 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Family Allergy and Asthma Research Institute" #1 sponsor was "Meda Pharmaceuticals" with 4 trials, followed by "Aimmune Therapeutics, Inc." with 3 trials sponsored, "Magna Pharmaceuticals, Inc." with 3 trials sponsored, "Amphastar Pharmaceuticals, Inc." with 2 trials sponsored and "Sunovion" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Family Allergy and Asthma Research Institute" #1 collaborator was "Syneos Health" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Family Allergy and Asthma Research Institute" are "Seasonal Allergic Rhinitis" (5 trials), "Peanut Allergy" (4 trials), "Asthma" (3 trials), "Chronic Spontaneous Urticaria" (2 trials) and "Rhinitis, Allergic, Seasonal" (2 trials). Many other conditions were trialed in "Family Allergy and Asthma Research Institute" in a lesser frequency.

Most popular intervention types in "Family Allergy and Asthma Research Institute" are "Drug" (15 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "AR101" (3 trials), "0.1% azelastine hydrochloride 1096 mcg daily" (1 trials), "0.15% azelastine hydrochloride 1644 mcg daily" (1 trials) and "AHIST NDC#58407-012-01" (1 trials). Other intervention names were less common.

The vast majority of trials in "Family Allergy and Asthma Research Institute" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Family Allergy and Asthma Research Institute". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 15 completed trials in Family Allergy and Asthma Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Family Allergy and Asthma Research Institute, 3 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".